Fin Trust Capital Advisors, LLC Abbott Laboratories Transaction History

Fin Trust Capital Advisors, LLC

$577 Million
Q3 2024

A detailed history of Fin Trust Capital Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Fin Trust Capital Advisors, LLC holds 4,447 shares of ABT stock, worth $512,605. This represents 0.09% of its overall portfolio holdings.

Number of Shares

4,447

Previous 4,457 0.22%

Holding current value

$512,605

Previous $463,000 9.5%

% of portfolio

0.09%

Previous 0.09%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	SELL	$100.07 - $118.13 $1,000 - $1,181	-10 Reduced 0.22%	4,447 $507,000
Q2 2024 Jul 24, 2024	BUY	$100.73 - $112.44 $47,645 - $53,184	473 Added 11.87%	4,457 $463,000
Q1 2024 May 02, 2024	BUY	$109.52 - $120.96 $51,583 - $56,972	471 Added 13.41%	3,984 $452,000
Q4 2023 Feb 13, 2024	SELL	$90.19 - $110.4 $10,732 - $13,137	-119 Reduced 3.28%	3,513 $386,000
Q3 2023 Oct 24, 2023	BUY	$95.53 - $114.62 $3,916 - $4,699	41 Added 1.14%	3,632 $351,000
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $7,414 - $8,698	-78 Reduced 2.13%	3,591 $394,000
Q3 2022 Oct 20, 2022	BUY	$96.76 - $112.03 $2,612 - $3,024	27 Added 0.74%	3,669 $385,000
Q2 2022 Jul 26, 2022	BUY	$102.07 - $123.37 $11,738 - $14,187	115 Added 3.26%	3,642 $398,000
Q1 2022 May 03, 2022	SELL	$114.02 - $139.04 $74,227 - $90,515	-651 Reduced 15.58%	3,527 $418,000
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $86,647 - $106,095	750 Added 21.88%	4,178 $588,000
Q3 2021 Nov 16, 2021	SELL	$116.66 - $129.06 $3,849 - $4,258	-33 Reduced 0.95%	3,428 $405,000
Q1 2021 May 17, 2021	BUY	$108.84 - $128.23 $4,788 - $5,642	44 Added 1.29%	3,461 $415,000
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $123,480 - $134,557	-1,176 Reduced 25.6%	3,417 $374,000
Q3 2020 Nov 10, 2020	SELL	$91.64 - $111.29 $188,228 - $228,589	-2,054 Reduced 30.9%	4,593 $500,000
Q2 2020 Sep 11, 2020	BUY	$76.57 - $98.0 $294,564 - $377,006	3,847 Added 137.39%	6,647 $608,000
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $20,137 - $25,774	263 Added 10.37%	2,800 $256,000
Q4 2019 Jan 23, 2020	SELL	$78.51 - $87.4 $4,710 - $5,244	-60 Reduced 2.31%	2,537 $220,000
Q2 2019 Aug 01, 2019	SELL	$72.88 - $85.0 $21,062 - $24,565	-289 Reduced 10.01%	2,597 $218,000
Q1 2019 May 09, 2019	SELL	$66.22 - $80.06 $37,215 - $44,993	-562 Reduced 16.3%	2,886 $231,000
Q4 2018 Feb 11, 2019	BUY	$65.56 - $74.27 $226,050 - $256,082	3,448 New	3,448 $250,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $202B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fin Trust Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fin Trust Capital Advisors, LLC with notifications on news.

Account

Fin Trust Capital Advisors, LLC Abbott Laboratories Transaction History